Get the Stockscreener App
207.47
1.20%
-2.545
Overview
News
Price History
Option Chain
Financials
Why DHR Down?
Discussions
Forecast
Stock Split
Dividend History
Danaher Corp stock is traded at $207.47, with a volume of 1.96M.
It is down -1.20% in the last 24 hours and down -13.22% over the past month.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
See More
Previous Close:
$210.01
Open:
$210.37
24h Volume:
1.96M
Relative Volume:
0.61
Market Cap:
$151.02B
Revenue:
$23.88B
Net Income/Loss:
$3.90B
P/E Ratio:
39.29
EPS:
5.28
Net Cash Flow:
$5.30B
1W Performance:
-6.84%
1M Performance:
-13.22%
6M Performance:
-21.20%
1Y Performance:
-15.87%
1-Day Range:
$206.66
$210.79
1-Week Range:
$206.66
$219.94
52-Week Range:
$206.66
$281.70
Danaher Corp Stock (DHR) Company Profile
Name
Danaher Corp
Sector
Industry
Phone
(202) 828-0850
Address
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
207.41 | 151.02B | 23.88B | 3.90B | 5.30B | 5.28 |
|
TMO
Thermo Fisher Scientific Inc
|
571.63 | 219.06B | 42.88B | 6.34B | 7.27B | 16.53 |
|
A
Agilent Technologies Inc
|
145.59 | 42.12B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
459.12 | 37.71B | 3.84B | 866.24M | 792.60M | 10.37 |
|
IQV
Iqvia Holdings Inc
|
207.67 | 36.97B | 15.32B | 1.41B | 1.96B | 7.62 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-03-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-31-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-18-23 | Initiated | HSBC Securities | Hold |
| Dec-13-23 | Resumed | Wolfe Research | Peer Perform |
| Dec-07-23 | Downgrade | Goldman | Buy → Neutral |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-01-23 | Initiated | SVB Securities | Outperform |
| Apr-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-18-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Oct-24-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-17-22 | Resumed | Bernstein | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jun-01-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-11-22 | Initiated | Bernstein | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-10-21 | Reiterated | BofA Securities | Buy |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Reiterated | Goldman | Buy |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Apr-07-21 | Resumed | Robert W. Baird | Outperform |
| Mar-03-21 | Resumed | Barclays | Overweight |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-16-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-02-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-26-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-03-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Resumed | Stifel | Hold |
| Oct-28-19 | Reiterated | Needham | Buy |
| Oct-14-19 | Resumed | Credit Suisse | Outperform |
| Jul-19-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Feb-25-19 | Upgrade | Janney | Neutral → Buy |
| Jan-03-19 | Initiated | Needham | Buy |
| Apr-20-18 | Reiterated | Stifel | Buy |
View All
Danaher Corp Stock (DHR) Latest News
Jim Cramer Likes This Utilities Stock: 'I Think You've Got A Good One' - Benzinga
Sumitomo Mitsui Trust Group Inc. Has $432.26 Million Stake in Danaher Co. (NYSE:DHR) - MarketBeat
William Blair Has Negative Estimate for Danaher Q1 Earnings - MarketBeat
Danaher Co. (NYSE:DHR) Shares Acquired by Calamos Wealth Management LLC - MarketBeat
Danaher Co. (NYSE:DHR) Shares Sold by CENTRAL TRUST Co - MarketBeat
Spire Wealth Management Sells 3,361 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Jim Cramer Discussed These 12 Stocks Recently - Insider Monkey
Compass Capital Management Inc. Boosts Stock Position in Danaher Co. (NYSE:DHR) - MarketBeat
Equities Analysts Offer Predictions for Danaher Q1 Earnings - MarketBeat
Danaher's (DHR) Market Perform Rating Reiterated at Raymond James - MarketBeat
Danaher (NYSE:DHR) Sets New 1-Year LowShould You Sell? - MarketBeat
Stock Yards Bank & Trust Co. Sells 1,724 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Robertson Stephens Wealth Management LLC Sells 3,294 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Mirae Asset Global Investments Co. Ltd. Trims Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
Ninety One UK Ltd Boosts Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
Greenleaf Trust Sells 1,213 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Co. (NYSE:DHR) Stake Boosted by Chicago Partners Investment Group LLC - MarketBeat
China Universal Asset Management Co. Ltd. Has $919,000 Position in Danaher Co. (NYSE:DHR) - MarketBeat
Cibc World Market Inc. Lowers Position in Danaher Co. (NYSE:DHR) - MarketBeat
Osborne Partners Capital Management LLC Boosts Stock Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Co. (NYSE:DHR) Shares Sold by DAVENPORT & Co LLC - MarketBeat
Danaher Unit Fights Amgen Subpoena in Fresenius Biosimilars Case - Bloomberg Law
Johnson Controls taps Danaher executive Joakim Weidemanis as next CEO - SecurityInfoWatch
Johnson Controls lifts 2025 profit forecast, names new CEO -February 05, 2025 at 08:24 am EST - Marketscreener.com
Johnson Controls names Danaher Corp. executive as next CEO - The Business Journals
Johnson Controls Names Weidemanis CEO, Logs 1Q Income Growth -February 05, 2025 at 07:55 am EST - Marketscreener.com
Lockheed Martin Investment Management Co. Has $4.26 Million Stake in Danaher Co. (NYSE:DHR) - MarketBeat
Johnson Controls Taps $15B Danaher Operations Chief as CEO in Strategic Leadership Move - StockTitan
Danaher Co. (NYSE:DHR) Shares Purchased by Sargent Investment Group LLC - MarketBeat
Yousif Capital Management LLC Sells 3,323 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Brian W. Ellis Sells 5,700 Shares of Danaher Co. (NYSE:DHR) Stock - MarketBeat
Drug Screening Market Share is booming in next 10 years | Danaher - openPR
Caprock Group LLC Makes New Investment in Danaher Co. (NYSE:DHR) - MarketBeat
William Blair Weighs in on Danaher's Q2 Earnings (NYSE:DHR) - MarketBeat
Norris Perne & French LLP MI Acquires 48,261 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Leerink Partnrs Forecasts Danaher's Q2 Earnings (NYSE:DHR) - MarketBeat
Promising Biotech Stocks To Add to Your WatchlistFebruary 04th - MarketBeat
Promising Industrial Stocks To Follow TodayFebruary 04th - MarketBeat
Greenwood Capital Associates LLC Sells 3,595 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
E. Ohman J or Asset Management AB Increases Stock Position in Danaher Co. (NYSE:DHR) - MarketBeat
HSBC Adjusts Price Target on Danaher to $290 From $300, Keeps Buy Rating -February 04, 2025 at 09:13 am EST - Marketscreener.com
Calamos Advisors LLC Has $46.22 Million Stock Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
BofA Cuts Danaher Stock Price Target to $265, Maintains Buy Rating - MSN
abrdn plc Has $248.68 Million Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
Raymond James downgrades Danaher on murky growth outlook - MSN
Danaher's Options: A Look at What the Big Money is Thinking - Benzinga
Is Danaher Corporation (DHR) the Best Cancer Stock to Buy According to Hedge Funds? - Insider Monkey
This FedEx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga
BDF Gestion Sells 2,481 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Danaher (NYSE:DHR) Receives "Outperform" Rating from Royal Bank of Canada - MarketBeat
Danaher Co. (NYSE:DHR) Shares Bought by Defender Capital LLC. - MarketBeat
Danaher Corp Stock (DHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.29%
2.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):